Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johanna Mercier
Pharma
Gilead CEO Daniel O'Day scores $19M in 2021 compensation
After a good news/bad news year for Gilead, CEO and board chairman Daniel O’Day was rewarded with a $19.2 million pay package.
Kevin Dunleavy
Mar 25, 2022 9:32am
Gilead reports $5.6B in '21 Veklury sales, projects $2B in '22
Feb 2, 2022 7:05am
Veklury sales boost Gilead’s top line to $7.4B
Oct 29, 2021 7:04am
Pharma's quarterly earnings shows lots of growth despite COVID
Aug 11, 2021 11:30am
Gilead's revenues fluctuate with the pandemic
Jul 30, 2021 1:00am
Remdesivir sales help buoy Gilead's losses in HIV, hepatitis C
Apr 30, 2021 8:10am